Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Valor Medical Inc.

This article was originally published in Start Up

Executive Summary

Valor Medical treats cerebral aneurysms with Neucrylate, which is injected through a microinfusion catheter introduced into the femoral artery of the leg, then passed up through the arterial system into the brain. Neucrylate is slowly delivered to the aneurysm in liquid form via a syringe. Once the product makes contact with blood, it immediately polymerizes into a soft, spongy solid to permanently relieve the blood pressure of the vessel wall of the aneurysm.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts